RaNA Therapeutics
Cambridge, US · Founded 2012 · Delaware corporation · 2 known investors
Biotech
Founders & leadership
RP
Robert PrentissExecutive
RC
Ronald C. Renaud, Jr.Executive
TM
Thomas McCauleyExecutive
Board
BG
Brian GallagherBoard director
JF
JR
Joshua ResnickBoard director
DL
Daniel LynchBoard director
OH
Owen HughesBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$162.3M disclosed across 3 rounds · 2015–2019
▶$47.5MraisedMay 2019 · 22 investors · BiotechnologyRule 506(b)
▶$47.5MraisedMay 2019 · 22 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jean-Francois FormelaDirector
- Daniella BeckmanDirector
- Robert M. PlengeDirector
- Richard WoosterExecutive Officer
- John R. SchroerExecutive Officer
- Michael HeartleinExecutive Officer
- Brian FentonExecutive Officer
- Paula CloghessyExecutive Officer
- Ronald Renaud, Jr.Executive Officer, Director
- Ann BarbierExecutive Officer
- Daniel S. LynchDirector
- Owen HughesDirector
- Robert J. MeyerDirector
- Paul BurgessExecutive Officer
- Offering amount
- $47.5M
- Amount sold
- $47.5M
- Sales commissions
- $2.8M
- Placement agents
- SVB Leerink LLC, Jefferies LLC
- First sale
- May 2019
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$51MraisedJan 2017 · 25 investors · BiotechnologyRule 506(b)
▶$51MraisedJan 2017 · 25 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Daniel LynchDirector
- Jean- Francois FormelaDirector
- Ronald Renaud, Jr.Executive Officer, Director
- Brian GallagherDirector
- Thomas McCauleyExecutive Officer
- Owen HughesDirector
- Offering amount
- $51M
- Amount sold
- $51M
- First sale
- Dec 2016
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$63.8MraisedJul 2015 · 27 investors · BiotechnologyRule 506(b)
▶$63.8MraisedJul 2015 · 27 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Brian GallagherDirector
- Jean Francois FormelaDirector
- Joshua ResnickDirector
- Robert PrentissExecutive Officer
- Daniel LynchDirector
- Ronald C. Renaud, Jr.Executive Officer, Director
- Offering amount
- $64.4M
- Amount sold
- $63.8M
- First sale
- Jul 2015
- Incorporated
- Limited Liability Company, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are RaNA Therapeutics's investors?
- RaNA Therapeutics's investors include Pfizer Venture Investments, Atlas Venture.
- How much funding has RaNA Therapeutics raised?
- RaNA Therapeutics has disclosed $162.3M raised across 3 rounds.
- Where is RaNA Therapeutics headquartered?
- RaNA Therapeutics is headquartered in Cambridge, US.